EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Evolution-based fragment growth protocol for design of potent RsmD inhibitors in mycobacterium tuberculosis

Mangal S Kadam, Ravikiran Yedidi, Burra V L S Prasad

Letters in Drug Design & Discovery · 2026-02 · 23 (2) · 100378

DOI: 10.1016/j.lddd.2026.100378 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Letters in Drug Design & Discovery, 2026-02. Verfasst von Mangal S Kadam und 2 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Kadam, M. S., Yedidi, R., & Prasad, B. V. L. S. (2026). Evolution-based fragment growth protocol for design of potent RsmD inhibitors in mycobacterium tuberculosis. Letters in Drug Design & Discovery, 23(2), 100378. https://doi.org/10.1016/j.lddd.2026.100378

Vancouver

Kadam MS, Yedidi R, Prasad BVLS. Evolution-based fragment growth protocol for design of potent RsmD inhibitors in mycobacterium tuberculosis. Letters in Drug Design & Discovery. 2026;23(2):100378. doi:10.1016/j.lddd.2026.100378

BibTeX
@article{Kadam2026,
  author = {Kadam, Mangal S and Yedidi, Ravikiran and Prasad, Burra V L S},
  title = {Evolution-based fragment growth protocol for design of potent RsmD inhibitors in mycobacterium tuberculosis},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {100378},
  doi = {10.1016/j.lddd.2026.100378}
}
Kostenlos starten →